| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.48▼ | 4.52▼ | 4.53▼ | 4.63▼ | 4.64▼ |
| MA10 | 4.52▼ | 4.52▼ | 4.50▼ | 4.64▼ | 4.11▲ |
| MA20 | 4.55▼ | 4.53▼ | 4.60▼ | 4.61▼ | 3.03▲ |
| MA50 | 4.50▼ | 4.72▼ | 4.73▼ | 4.06▲ | 1.91▲ |
| MA100 | 4.57▼ | 4.71▼ | 4.67▼ | 2.94▲ | 1.62▲ |
| MA200 | 4.76▼ | 4.67▼ | 4.56▼ | 2.06▲ | 6.19▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.015▼ | 0.010▲ | -0.007▼ | -0.058▼ | 0.140▲ |
| RSI | 42.373▼ | 39.368▼ | 38.862▼ | 51.011▲ | 65.501▲ |
| STOCH | 9.896▼ | 64.503 | 44.506 | 49.683 | 64.952 |
| WILL %R | -100.000▼ | -66.667 | -76.471▼ | -59.459 | -41.545 |
| CCI | -95.995 | -58.581 | -72.747 | -64.831 | 62.141 |
|
Sunday, March 08, 2026 08:02 PM
If MASH becomes a routinely managed chronic disease-similar to diabetes or obesity-the healthcare system will require diagnostic tools capable of handling dramatically higher patient volumes. ENDRA's ...
|
|
Monday, January 12, 2026 07:16 AM
(RTTNews) - AN2 Therapeutics Inc. (ANTX) announced that the U.S. FDA has cleared its investigator-initiated trial evaluating Epetraborole in 90 patients with Mycobacterium abscessus lung disease, ...
|
|
Tuesday, August 13, 2024 07:01 PM
AN2 Therapeutics (NASDAQ:ANTX) just reported results for the second quarter of 2024. AN2 Therapeutics reported earnings per share of -48 cents. This was above the analyst estimate for EPS of -59 cents ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/05/26 | 4.385 | 4.625 | 4.385 | 4.465 | 54,457 |
| 28/05/26 | 4.61 | 4.74 | 4.40 | 4.46 | 191,926 |
| 27/05/26 | 4.74 | 4.92 | 4.61 | 4.63 | 117,697 |
| 26/05/26 | 4.88 | 5.07 | 4.68 | 4.73 | 535,878 |
| 22/05/26 | 4.89 | 5.235 | 4.67 | 4.85 | 731,454 |
| 21/05/26 | 4.60 | 4.92 | 4.45 | 4.89 | 102,358 |
| 20/05/26 | 4.49 | 4.67 | 4.44 | 4.59 | 68,672 |
| 19/05/26 | 4.51 | 4.68 | 4.31 | 4.55 | 83,628 |
| 18/05/26 | 4.75 | 4.91 | 4.27 | 4.48 | 134,179 |
| 15/05/26 | 4.70 | 4.95 | 4.50 | 4.75 | 408,710 |
|
|
||||
|
|
||||
|
|